Allernaze | Triamcinolone Acetonide Spray, Metered Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Allernaze | Triamcinolone Acetonide Spray, Metered while breastfeeding. We will also discuss about common side effects and warnings associated with Allernaze | Triamcinolone Acetonide Spray, Metered.

What is Allernaze | Triamcinolone Acetonide Spray, Metered used for?


: AllerNaze is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 12 years of age or older.

Is using Allernaze | Triamcinolone Acetonide Spray, Metered unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Allernaze | Triamcinolone Acetonide Spray, Metered low risk for breastfeeding
Triamcinolone acetonide is the one and only active ingredient present in Allernaze | Triamcinolone Acetonide Spray, Metered. Triamcinolone acetonide in itself is a low risk drug for lactation so it is easy to understand that Allernaze | Triamcinolone Acetonide Spray, Metered also comes in category of Low Risk item while breastfeeding. Below is the summary of Triamcinolone acetonide in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
NURSING MOTHERS: It is not known whether triamcinolone acetonide is excreted in human breast milk. Because other corticosteroids are excreted in human milk, caution should be exercised when AllerNaze is administered to nursing women.

Allernaze | Triamcinolone Acetonide Spray, Metered Breastfeeding Analsys


Triamcinolone acetonide while Breastfeeding

Low Risk

CAS Number: 76-25-5

A corticosteroid with a mainly glucocorticoid action and anti-inflammatory effects of similar strength to that of prednisolone.Systemic administration (oral, injection), inhaled (bronchial, nasal), intra-articular, intravitreous and topical.Indicated in the treatment of rheumatic diseases and collagen, inflammatory bowel disease, dermatitis, asthma, rhinitis, etc. This comment is about systemic, intra-articular and ophthalmic triamcinolone. Since the last update we have not found published data about its excretion in breast milk. Administration of intra-articular triamcinolone in the wrist (Smuin 2016) or via an epidural in the cervical area (McGuire 2012) caused a temporary decrease in the production of milk lasting between one and four weeks that was resolved in both cases via the continuation and stimulation of breastfeeding. The same has occurred, with a shorter duration, following the intra-articular administration of methylprednisolone (Babwah 2013). Although after the administration of triamcinolone, both intraocular (Shen 2010, Degenring 2004), and epidural (Hooten 2016), elimination half-life is about 22-25 days, plasma levels are indetectable or very low, not clinically significant. The maximum concentration peak after these types of administration occurs at 24 hours (Hooten 2016, Shen 2010, Degenring 2004). There is consensus among experts that, in general, neither systemic corticoids nor inhaled ones present a breastfeeding contraindication (National Asthma Education 2004). The low plasma levels obtained after ophthalmic administration suggest a very low risk during breastfeeding. Corticoids are of commonally used in pediatrics and have no side effects when they are used in isolation or in short-term treatments. Until there is more published data about this drug in relation to breastfeeding, alternatives with a safer known pharmacokinetic profile for breastfeeding may be preferable (greater protein binding, lesser half-life and less oral bioavailability), especially during the neonatal period and in case of prematurity. If used during breastfeeding it is advisable to monitor milk production. See below the information of these related products:



What should I do if already breastfed my kid after using Allernaze | Triamcinolone Acetonide Spray, Metered?

Allernaze | Triamcinolone Acetonide Spray, Metered is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Allernaze | Triamcinolone Acetonide Spray, Metered so you should inform him based on your convenience.


My health care provider has asked me to use Allernaze | Triamcinolone Acetonide Spray, Metered, what to do?

Allernaze | Triamcinolone Acetonide Spray, Metered comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Allernaze | Triamcinolone Acetonide Spray, Metered, will my baby need extra monitoring?

Not much monitoring required while using Allernaze | Triamcinolone Acetonide Spray, Metered


Who can I talk to if I have questions about usage of Allernaze | Triamcinolone Acetonide Spray, Metered in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients